Myocarditis, ontsteking van de hartspier komt voor als bijwerking van mRNA vaccins, het risico hierop is echter 1000 x zo laag als bij een active infectie met het SARS-COV-2 virus zelf. In die zin zou je kunnen zeggen dat vaccinatie dus ook beschermd tegen een ontsteking van de hartspier. Het risico is hoger bij mannen onder de 30 jaar. Literatuur1. Aikawa T, Takagi H, Ishikawa K, Kuno T. Myocardial injury characterized by elevated cardiac troponin and in‐hospital mortality of COVID‐19: an insight from a meta‐analysis. J Med Virol. 2020;93(1):10.1002/jmv.26108.2. Maiese A, Frati P, Duca FD, Santoro P, Manetti AC, Russa RL, et al. Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review. Diagnostics. 2021;11(9):1647.3. Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. New Engl J Medicine. 2021;385(23):NEJMoa2109730.4. Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19(2):75–7.5. Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. New Engl J Medicine. 2021;385(23):NEJMoa2110737.6. Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. Jama Cardiol. 2021;6(10):1202–6.7. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol Orlando Fla. 2020;217:108480–108480.8. Heymans S, Eriksson U, Lehtonen J, Cooper LT. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J Am Coll Cardiol. 2016;68(21):2348–64.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related